For decades, Tennessee occupied a relatively predictable place in the national litigation landscape. Cases generally developed deliberately rather than theatrically. Discovery proceeded at a measured pace. Trial remained comparatively uncommon outside a handful of venues. Medical treatment typically occurred through traditional healthcare channels, with bills paid through commercial insurance, Medicare, TennCare, or employer-sponsored plans.
Although Tennessee has never been immune from aggressive personal injury litigation, it has not historically housed the extensive infrastructure of litigation-centered medical providers that have become commonplace in jurisdictions such as Florida, California, and Texas. Here cases turn largely on familiar questions of liability, causation, and damages documented through conventional medical records and established treatment relationships. Cases could certainly become expensive, but the machinery surrounding them remained comparatively predictable. That predictability is beginning to erode.
Tennessee has experienced a noticeable increase in advertising by plaintiffs' firms employing marketing strategies popular in other major litigation markets. Billboards line interstate highways. Digital advertising follows consumers across social media. Television, streaming services, transit advertising, and even park benches carry variations of the same message.
The sustained visibility of plaintiffs' firms affects the broader cultural environment in which claims are evaluated. Repeated messaging about insurance companies, corporate accountability, denied claims, and the need to "fight" for compensation can reinforce a narrative in which carriers and corporate defendants are viewed with skepticism before a particular dispute ever reaches the courtroom. Over time, those messages can become part of the background against which prospective jurors understand the civil justice system.
Jurors do not enter the courthouse insulated from the advertising and messaging they encounter every day. When a market becomes saturated with advertisements portraying plaintiffs' lawyers as the counterweight to powerful insurers and corporations, defense counsel may increasingly encounter jurors predisposed to question whether an insurer has treated an injured person fairly or whether a corporate defendant is accepting responsibility. The attitudes cultivated by broader messaging can influence how jurors perceive corporate conduct, damages, and the relative credibility of the parties.
This phenomenon is particularly significant when combined with the sophisticated trial strategies that have developed in other high-exposure jurisdictions. The same litigation environment that produces larger medical damages models and more aggressive case development can also produce a jury pool increasingly receptive to themes of institutional distrust, corporate indifference, and the need for jurors to "send a message." The proliferation of billboard advertising in Tennessee deserves attention beyond its obvious marketing purpose. What follows the advertising can ultimately matter far more than the advertising itself.
The Playbook is Not New: Miami as a Case Study
Miami is an ideal case study. It is not unusual for a successful local practice using now nationally recognized billboards to explode into one of the largest plaintiff firms in the country. The personal injury litigation model in South Florida changed significantly with the inundation of plaintiff advertising.
In addition to increased publicity, several developments occurred simultaneously. Letters of protection became increasingly common. Medical practices catering heavily to litigation patients proliferated. Traumatic brain injury allegations began appearing with greater frequency, including in cases that historically might have involved primarily orthopedic complaints. Future medical damages expanded. The gap between amounts billed for medical services and amounts ordinarily reimbursed for comparable care became increasingly important to case valuation.
Perhaps most consequential, the pace of litigation accelerated. Cases that once may have developed gradually were pushed aggressively from the moment suit was filed. Experts entered the case earlier. Damages theories took shape sooner. Plaintiffs' counsel increasingly dictated the tempo of litigation rather than simply responding to defense strategy.
At approximately the same time, the rise of the "reptile" approach altered the way many plaintiffs' lawyers presented cases to juries. Safety rules, corporate conduct, community protection, and emotionally resonant damages narratives became increasingly sophisticated components of trial strategy. Many of the techniques now associated with social inflation and so-called nuclear verdicts developed or matured during this broader evolution in plaintiffs' practice. Having tried cases against lawyers who were at the forefront of that movement, I recognize some of the same early indicators now appearing in Tennessee.
The Damages Model is Beginning to Change
Perhaps the clearest evidence of the shift can be found in medical damages. Historically, future medical care in Tennessee was more likely to be evaluated against realistic regional costs and conventional reimbursement practices. A projected anterior cervical discectomy and fusion, for example, could be assessed by reference to what that procedure actually costs in the Tennessee healthcare market. Increasingly, defense counsel are encountering future medical projections that bear less obvious relationship to those reimbursement realities. Projected surgical costs are higher. Treatment recommendations are more extensive. Traumatic brain injury allegations are appearing in cases where they once would have been unusual. Letters of protection are becoming a more significant part of the treatment and damages landscape.
The issue is not whether every recommendation is unwarranted, or every projected cost inflated. Those are case-specific questions, and ultimately the evidence will speak for itself. The larger concern is structural. When the economic model underlying a plaintiff's medical treatment changes, the damages model built upon the treatment changes with it. That has consequences far beyond the amount appearing on a medical bill.
More Than a Medical Billing Dispute
It is tempting to tout letters of protection and litigation-associated medical treatment as discrete discovery issues. In fact, medical charges can become the foundation for virtually every subsequent component of a plaintiff's damages presentation. They inform settlement demands. They influence expert opinions. They feed life care plans and future medical projections. They can provide anchors for noneconomic damages arguments and affect the perceived value of the case long before a jury is selected.
If the underlying numbers reflect a litigation-driven economic model rather than ordinary healthcare reimbursement, the distinction matters. It requires defense counsel to ask more than whether a particular treatment was medically necessary. The inquiry must also examine:
- How the treatment relationship arose,
- Why a particular provider was selected,
- The extent to which the provider treats patients involved in litigation,
- The methodology supporting the charges, and
- How those amounts compare with actual market reimbursement for comparable care.
Future damages require the same scrutiny:
- Are projected costs based on what providers actually accept for the procedure in the relevant market?
- Do they reflect commercial reimbursement rates or billed charges?
- Are the assumptions underlying a life care plan consistent with the way healthcare is ordinarily purchased and paid for in Tennessee?
Increasingly, these questions are not collateral to the damages analysis. They are the damages analysis.
Defense Strategy Must Evolve with Claims
One of the most important lessons from Florida is that waiting for a plaintiff's damages theory to fully develop before confronting it can place the defense at an immediate disadvantage. Once a narrative becomes embedded in the case, dismantling it becomes considerably more difficult.
In mature high-exposure litigation markets, defense practice has become increasingly proactive. Appropriate experts are identified earlier. Medical billing receives scrutiny before discovery is substantially complete. Treating providers and referral relationships are examined closely. Future medical projections are tested against actual market data. Complex injury allegations are evaluated before they become accepted premises of the litigation. The same approach may become increasingly necessary in Tennessee.
Traumatic brain injury claims, for example, may require coordinated analysis involving neurologists, neuroradiologists, neuropsychologists, biomechanical experts, or other appropriate specialists depending upon the facts of the case. Medical damages may require expertise not only concerning necessity and causation, but also the reasonable value of the services provided. The bottom line is the defense cannot allow the plaintiff to be the only party defining the case.
A damages demand supported by treatment records, expert opinions, and a life care plan can acquire an appearance of inevitability if its underlying assumptions are not challenged early. Effective defense strategy requires identifying those assumptions, testing them through discovery, and developing an evidence-based alternative before the plaintiff's valuation becomes the default framework through which everyone views the case.
The same principle applies to jury strategy. If broader cultural messaging has contributed to skepticism toward insurers and defendants, jury selection strategy becomes critical. Defense counsel must understand not simply what prospective jurors know about the case, but the assumptions they may bring with them about corporations, insurance, personal injury litigation and the civil justice system itself.
Tennessee Is at an Inflection Point
Advertising changes the volume and types of claims entering the system. It can also influence the public narratives surrounding those claims. Sophisticated national firms bring strategies developed and refined in other jurisdictions, Changes in medical economics affect the presentation of damages. Larger demands influence settlement behavior. New approaches to case development eventually influence how both sides litigate. The relevant question, therefore, is not whether Tennessee will replicate the experience of another state. It is whether the forces that transformed personal injury litigation elsewhere are beginning to exert greater influence here.
For defense counsel, insurers, and businesses facing significant personal injury exposure, the appropriate response is neither alarm nor complacency. It is preparation. Tennessee has the benefit of watching what occurred in jurisdictions and learning from their experience.
That means recognizing emerging damages issues for what they may represent. A dispute over the reasonable value of a medical procedures may not be simply a dispute over a bill. An increasingly aggressive life care plan may not be isolated valuation problem. A new pattern of treatment, referral, and expert involvement may signal something broader about the way cases are being developed. A proliferation of plaintiff advertising may represent more than competition for clients. Over time, it may help shape the assumptions about insurers, corporations, accountability, and damages that jurors carry with them into the courtroom.
Those who have practice through similar transitions elsewhere know how quickly these developments can move from emerging trends to established features of the litigation landscape. Tennessee does not have to wait until they do to respond.
